Latest News

Pharmacist’s Application to Practice: Tislelizumab-jsgr

Kristine Pisikian, PharmD, PGY-1 Pharmacist Resident and Caroline Quinn, PharmD, BCOP, Specialty Clinical Program Director at Prime Therapeutics write about Tislelizumab-jsgr.

Metastatic Colorectal Cancer
Journal Club

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

The data from this trial confirm that FTD–TPI plus bevacizumab is an effective treatment option for patients with refractory metastatic colorectal cancer, irrespective of mutational status, which side the tumor is on, and whether patients have previously

Collaborations BCOP

HOPA Curated BCOP CE Program (Part of Oncology Pharmacists Connect)

HOPA's BCOP Program presents highly sought after education at an affordable price. Join us following the Oncology Pharmacists Connect!

Jolynn Sessions giving her incoming president's address at HOPA
HOPA Members

HOPA President Committed to Direct Patient Care, Especially for Veterans with Cancer

Dr. Sessions has dedicated her career to providing direct patient care, and currently to veterans with cancer.

black and white photo of woman of color receiving IV chemo
HOPA Members

Combating Health Disparities within Indigenous Communities Amid Cancer Treatment

Learn how a HOPA Member connects research with his intimate knowledge of health disparities amongst sovereign Indigenous nations across the US.

Tools and Resources

Standardization of IDS Key Performance Indicators and Metrics; Results of a HOPA IDS SIG Survey

The Hematology/Oncology Pharmacy Association has helped establish practical guidance for Investigational Services metrics and site utilization.

HOPA Members

HOPA's Conference a Notable Event for Tampa Convention Center

Immediate Past President LeAnne Kennedy gave Spectrum News 9 a tour of HOPA2024 at the Tampa Convention Center and talked about being back at the TCC after COVID-19 disrupted HOPA's conference in 2020

medical illustration of inflamation from osteoporosis

Late-Breaking HOPA News: Severe Hypocalcemia in Patients with Advanced Chronic Kidney Disease on Denosumab Therapy

Originally approved for the treatment of osteoporosis in postmenopausal women at high risk for fractures, denosumab is now frequently used in the management of hypercalcemia of malignancy and to decrease skeletal-related events for certain cancer patients

Late-Breaking HOPA News: T-cell Malignancies with CAR T-cell therapy

In November 2023, the FDA announced their investigation of reports of T-cell lymphomas from clinical trials and post-marketing adverse event data sources for CAR T-cell immunotherapies. In January 2024, the FDA issued Safety Labeling Change notification.

Collaborations Patient Resources

HOPA and Cancer Support Community Bring Together Patient and Pharmacist Points of View

The Hematology/Oncology Pharmacy Association (HOPA) has partnered with Cancer Support Community (CSC) for a live video interview with an oncology pharmacist and cancer patient.

-positive non-small cell lung cancer
Drug Updates

Pharmacist’s Application to Practice: Repotrectinib

Christopher L. Cornett II, PharmD PGY1 Acute Care Pharmacy Resident Anne E Hitron, PharmD, MS, MBA, BCOP ,Oncology Pharmacy Specialist, Baptist Health Louisville, Louisville, Kentucky

uveal melanoma with unresectable hepatic metastases
Drug Updates

Pharmacist’s Application to Practice: Hepzato Kit™

Lainey Vargo, PharmD, PGY2-Oncology Resident Katie Murto, PharmD, BCOP and Crystal Heise, PharmD, BCOP WVUH Hospitals, Morgantown, West Virginia.